Claims
- 1. A prostaglandin analog of the formula ##STR1## wherein g is one, 2, or 3; WHEREIN Y is trans--CH=CH--;
- wherein M.sub.1 is ##STR2## wherein R.sub.5 is hydrogen or methyl; WHEREIN M IS ONE TO 5, INCLUSIVE;
- Wherein L.sub.1 is ##STR3## wherein R.sub.3 and R.sub.4 are hydrogen, methyl, or fluoro, being the same or different, with the proviso that one of R.sub.3 and R.sub.4 is fluoro only when the other is hydrogen or fluoro; and wherein
- R.sub.1 is hydrogen, alkyl of one to 12 carbon atoms, inclusive, cycloalkyl of 3 to 10 carbon atoms, inclusive, aralkyl of 7 to 12 carbon atoms, inclusive, phenyl, phenyl substituted with one, two, or three chloro or alkyl of one to 3 carbon atoms, inclusive, or a pharmacologically acceptable cation.
- 2. A compound according to claim 1, wherein M.sub.1 is ##STR4##
- 3. A compound according to claim 1, wherein M.sub.1 is ##STR5##
- 4. A compound according to claim 3, wherein g is 3.
- 5. A compound according to claim 4, wherein m is 3.
- 6. A compound according to claim 5, wherein R.sub.3, R.sub.4, and R.sub.5 are all hydrogen.
- 7. 2A,2B-Dihomo-4,4,5,5-tetradehydro-11-deoxy-PGE.sub.1, methyl ester, a compound according to claim 6.
- 8. A compound according to claim 3, wherein g is one.
- 9. A compound according to claim 8, wherein m is 3.
- 10. A compound according to claim 9, wherein R.sub.3 and R.sub.4 are both hydrogen.
- 11. A compound according to claim 10, wherein R.sub.5 is methyl.
- 12. 4,4,5,5-Tetradehydro-15-methyl-11-deoxy-PGE.sub.1, methyl ester, a compound according to claim 11.
- 13. 4,4,5,5-Tetradehydro-15-methyl-11-deoxy-PGE.sub.1, a compound according to claim 11.
- 14. A compound according to claim 10, wherein R.sub.5 is hydrogen.
- 15. 4,4,5,5-Tetradehydro-11-deoxy-PGE.sub.1, a compound according to claim 14.
- 16. 4,4,5,5-Tetradehydro-11-deoxy-PGE.sub.1, methyl ester, a compound according to claim 14.
- 17. A compound according to claim 9, wherein at least one of R.sub.3 and R.sub.4 is methyl.
- 18. A compound according to claim 17, wherein R.sub.3 and R.sub.4 are both methyl.
- 19. A compound according to claim 18, wherein R.sub.5 is methyl.
- 20. 4,4,5,5-Tetradehydro-15,16,16-trimethyl-11-deoxy-PGE.sub.1, a compound according to claim 19.
- 21. 4,4,5,5-Tetradehydro-15,16,16-trimethyl-11-deoxy-PGE.sub.1, methyl ester, a compound according to claim 19.
- 22. A compound according to claim 18, wherein R.sub.5 is hydrogen.
- 23. 4,4,5,5-Tetradehydro-16,16-dimethyl-11-deoxy-PGE.sub.1, a compound according to claim 22.
- 24. 4,4,5,5-Tetradehydro-16,16-dimethyl-11-deoxy-PGE.sub.1, methyl ester, a compound according to claim 22.
- 25. A compound according to claim 9, wherein at least one of R.sub.3 and R.sub.4 is fluoro.
- 26. A compound according to claim 25, wherein R.sub.3 and R.sub.4 are both fluoro.
- 27. A compound according to claim 26, wherein R.sub.5 is methyl.
- 28. 4,4,5,5-Tetradehydro-15-methyl-16,16-difluoro-11-deoxy-PGE.sub.1, a compound according to claim 27.
- 29. 4,4,5,5-Tetradehydro-15-methyl-16,16-difluoro-11-deoxy-PGE.sub.1, methyl ester, a compound according to claim 27.
- 30. A compound according to claim 26, wherein R.sub.5 is hydrogen.
- 31. 4,4,5,5-Tetradehydro-16,16-difluoro-11-deoxy-PGE.sub.1, a compound according to claim 27.
- 32. 4,4,5,5-Tetradehydro-16,16-difluoro-11-deoxy-PGE.sub.1, methyl ester, a compound according to claim 30.
Parent Case Info
The present application is a divisional application of Ser. No. 619,077, filed Oct. 2, 1975, now issued as U.S. Pat. No. 4,013,695, on Mar. 22, 1977.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
3933889 |
Magerlin |
Jan 1976 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
619077 |
Oct 1975 |
|